To evaluate the clinical impact of tumor PD-L2 in stage I-IV colon carcinoma, we used immunohistochemical analysis to detect the protein expression of tumor PD-L2 (n = 1264, Table 1). The gene discussed is PDCD1LG2; the disease is neoplasm.